首页> 美国卫生研究院文献>Research Involvement and Engagement >Patients’ clinicians’ and the research communities’ priorities for treatment research: there is an important mismatch
【2h】

Patients’ clinicians’ and the research communities’ priorities for treatment research: there is an important mismatch

机译:患者临床医生和研究社区的治疗研究重点:存在重大不匹配

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Plain English summaryThere is some evidence that there is a mismatch between what patients and health professionals want to see researched and the research that is actually done. The James Lind Alliance (JLA) research Priority Setting Partnerships (PSPs) were created to address this mismatch. Between 2007 and 2014, JLA partnerships of patients, carers and health professionals agreed on important treatment research questions (priorities) in a range of health conditions, such as Type 1 diabetes, eczema and stroke. We were interested in how much these JLA PSP priorities were similar to treatments undergoing evaluation and research over the same time span. We identified the treatments described in all the JLA PSP research priority lists and compared these to the treatments described in a group of research studies (randomly selected) registered publically. The priorities identified by JLA PSPs emphasised the importance of non-drug treatment research, compared to the research actually being done over the same time period, which mostly involved evaluations of drugs. These findings suggest that the research community should make greater efforts to address issues of importance to users of research, such as patients and healthcare professionals.
机译:简单的英语摘要有一些证据表明,患者和卫生专业人员想要进行的研究与实际完成的研究之间存在不一致。詹姆斯·林德联盟(JLA)的研究确定优先级合作伙伴(PSP)就是为了解决这种不匹配而创建的。在2007年至2014年期间,JLA患者,护理人员和卫生专业人员的合作伙伴就一系列健康状况(例如1型糖尿病,湿疹和中风)的重要治疗研究问题(优先级)达成了共识。我们对JLA PSP的这些优先级与在同一时间段内接受评估和研究的治疗有多少相似之处感兴趣。我们确定了所有JLA PSP研究优先级列表中描述的治疗方法,并将它们与公开注册的一组研究研究(随机选择)中描述的治疗方法进行了比较。与同期进行的研究相比,JLA PSP所确定的优先事项强调了非药物治疗研究的重要性,该研究主要涉及药物评估。这些发现表明,研究界应做出更大的努力,以解决对研究用户(例如患者和医疗保健专业人员)重要的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号